<DOC>
	<DOCNO>NCT02237612</DOCNO>
	<brief_summary>This pilot clinical trial study well diffusion-weighted magnetic resonance imaging ( MRI ) work stag patient prostate cancer spread nearby lymph node part body . New image technique , diffusion-weighted MRI , may less invasive way predict stage grade prostate cancer .</brief_summary>
	<brief_title>Diffusion-Weighted MRI Staging Patients With Localized Prostate Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine sensitivity specificity diffusion-weighted MRI pathologic T3 stage prostate cancer use 3 Tesla ( 3T ) magnet surface coil . OUTLINE : Patients undergo diffusion-weighted MRI pelvis .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Biopsydocumented adenocarcinoma prostate intermediate high risk , define possess one follow feature : Gleason &gt; = 7 &gt; 50 % biopsy core + Prostatespecific antigen ( PSA ) &gt; = 10 Interested undergoing radical prostatectomy definitive management prostate cancer No clinical radiographic evidence distant metastatic disease In subject PSA &lt; 20 radiographic staging require absence clinical symptom distant metastatic disease ; PSA &gt; 20 , bone scan must document lack concern bone involvement Ineligible surgery due cardiac , pulmonary , major comorbidity factor History claustrophobia Pacemaker implant metal object would make subject ineligible MRI , per standard criterion Unable give write informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>